Literature DB >> 7705924

Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine.

A Albini1, F D'Agostini, D Giunciuglio, I Paglieri, R Balansky, S De Flora.   

Abstract

The thiol N-acetylcysteine (NAC) is currently considered one of the most promising cancer chemopreventive agents by virtue of its multiple and coordinated mechanisms affecting the process of chemical carcinogenesis. Recent studies have shown that an unpaired cysteine residue in the propeptide plays a key role in inactivation of latent metastasis-associated metalloproteinases: the present study was designed to assess whether NAC could also affect tumor take, invasion and metastasis of malignant cells. As assessed by zymographic analysis, NAC completely inhibited the gelatinolytic activity of type-IV collagenases in the cells tested (gelatinases A and B). Moreover, NAC was efficient in inhibiting the chemotactic and invasive activities of tumor cells of human (A2058 melanoma) and murine origin (K1735 and B16-F10 melanoma cells as well as C87 Lewis lung carcinoma cells) in Boyden-chamber assays, which are predictive of the invasive and metastatic properties. Reduced glutathione (GSH) had a similar, although less effective activity. The number of lung metastases decreased sharply when B16-F10 murine melanoma cells, injected i.v. into nude mice, were pre-treated with NAC and resuspended in medium supplemented with 10 mM NAC. In other experiments NAC was given in drinking water, starting 48-72 hr before subcutaneous inoculation of either B16-F10 cells or of their highly metastatic variant B16-BL6, or intramuscular injection of LLC cells. In all experiments NAC treatment decreased the weight of the locally formed primary tumor and produced a dose-related delay in tumor formation. Spontaneous metastasis formation by B16-F10 and B16-BL6 tumors was slightly yet significantly reduced by oral administration of NAC. However, this was not observed for Lewis lung tumors. These data indicate that NAC affects the process of tumor-cell invasion and metastasis, probably due to inhibition of gelatinases by its sulfhydryl group, with the possible contribution of other mechanisms, including the potent antioxidant activity of this thiol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705924     DOI: 10.1002/ijc.2910610121

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  p53-independent inhibition of proliferation and p21(WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E.

Authors:  J L Nargi; R R Ratan; D E Griffin
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data.

Authors:  Peng-Chan Lin; Ming-Yang Lee; Wei-Shu Wang; Chueh-Chuan Yen; Ta-Chung Chao; Liang-Tsai Hsiao; Muh-Hwa Yang; Po-Min Chen; Kon-Ping Lin; Tzeon-Jye Chiou
Journal:  Support Care Cancer       Date:  2006-02-01       Impact factor: 3.603

3.  Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane.

Authors:  A M Sieuwerts; J G Klijn; J A Foekens
Journal:  Clin Exp Metastasis       Date:  1997-01       Impact factor: 5.150

4.  Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation.

Authors:  K Harimaya; K Tanaka; Y Matsumoto; H Sato; S Matsuda; Y Iwamoto
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Cleistanthin A inhibits the invasion of MDA-MB-231 human breast cancer cells: involvement of the β-catenin pathway.

Authors:  Siyuan Liu; Lu Wang; Wangwang Ding; Dan Wang; Xueting Wang; Qianqian Luo; Yapeng Lu; Li Zhu
Journal:  Pharmacol Rep       Date:  2019-12-19       Impact factor: 3.024

6.  High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis.

Authors:  Dimitrios Mougiakakos; Riki Okita; Takashi Ando; Christoph Dürr; Jules Gadiot; Jiro Ichikawa; Robert Zeiser; Christian Blank; C Christian Johansson; Rolf Kiessling
Journal:  J Mol Med (Berl)       Date:  2012-01-17       Impact factor: 4.599

7.  Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells.

Authors:  J Carretero; E Obrador; M J Anasagasti; J J Martin; F Vidal-Vanaclocha; J M Estrela
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

8.  Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.

Authors:  Dhivya Sridaran; Ganesan Ramamoorthi; Rasool MahaboobKhan; Premkumar Kumpati
Journal:  Tumour Biol       Date:  2016-07-26

9.  N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer.

Authors:  Anshu Agarwal; Ursula Muñoz-Nájar; Ulrike Klueh; Shu-Ching Shih; Kevin P Claffey
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

10.  The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.

Authors:  Yu Sun; Basil Rigas
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.